Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest EPS
Below are the top mid-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of earnings per share.
The trailing-twelve-month earnings per share at Watson Pharmaceuticals Inc (NYSE: WPI) is $2.06. WPI's ROE for the same period is 7.57%.
The trailing-twelve-month earnings per share at Medicis Pharmaceutical Corp (NYSE: MRX) is $1.88. MRX's PEG ratio is 1.13.
The trailing-twelve-month earnings per share at Salix Pharmaceuticals Ltd (NASDAQ: SLXP) is $1.44. SLXP's PEG ratio is 0.87.
The trailing-twelve-month earnings per share at Mylan Inc (NASDAQ: MYL) is $1.22. MYL's operating margin for the same period is 17.20%.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Drugs-Generic Industry Highest EPS Mid-CapTrading Ideas